New Gene Therapy Treatment Showing Promise against ‘Bubble Boy’ Disease
October 10, 2014
(Fox News) – More than a decade ago, doctors showed dramatic progress in helping infants born with a severe deficiency in their immune systems, a condition known as “bubble boy” disease. But when one quarter of treated children developed leukemia within two to five years, researchers went back to the drawing board. Now a new variation of that therapy, which also uses a genetically-engineered virus to help the body create disease-fighting T-cells, is showing similar early promise, and none of the children who have received the therapy have show any evidence of cancer, according to preliminary results reported in the New England Journal of Medicine.